Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons

NCT: NCT02509663 · TERMINATED

NCT IDNCT02509663
StatusTERMINATED
Start Date2018-06-15
Completion2019-07-31
SponsorUniversity Hospital, Strasbourg, France (OTHER)
First posted
Last updated

Brief Summary

The sinuplasty balloon offers a more physiological first of the sinuses which minimizes risks associated to traditional surgery. Its atraumatic characteristic also helps to reduce the risk of bleeding (so any use of Pack), limit scarring ransom, reduce the post-operative pain, ensure faster return to daily life activities (reduction of the average length of hospitalization). Patient's quality of life would be improved (SNOT-22 questionnaire) and reduction of post-operative pain score seams decrease on EVA. The economic impact of the sinuplasty balloon appears very favourable and fits into the strategy of development of the ambulatory practice.

Frequently Asked Questions

What is Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons?

Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons is a clinical trial registered under NCT02509663. Current status: TERMINATED.

What is the status of NCT02509663?

The current status of NCT02509663 (Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons) is: TERMINATED.

When did Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons start?

Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons started on 2018-06-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.